Back to STIFEL FINANCIAL CORP STIFEL FINANCIAL CORP

RGNXRGNX
Showing 8 of 20 quarters

Position history for STIFEL FINANCIAL CORPSTIFEL FINANCIAL CORP's holdings in REGENXBIO INC

STIFEL FINANCIAL CORP holds 392,769 shares of RGNX (REGENXBIO INC), worth $3.3M as of 2026-Q1. The position was increased (+17.2% shares). RGNX represents 0.0% of STIFEL FINANCIAL CORP's portfolio.

Current Value

$3.3M

Current Shares

392,769

Total Value Change

+$1.8M

Total Shares Change

+261,052

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
392,769
+17.2%
$3.3M0.0%$8.69
31
2025-Q4
Increased
335,046
+4.6%
$4.8M0.0%$14.09
28
2025-Q3
Increased
320,410
+3.0%
$3.1M0.0%$9.85
27
2025-Q2
Decreased
311,107
-5.4%
$2.6M0.0%$8.39
0
2025-Q1
Increased
328,966
+74.2%
$2.4M0.0%$7.83
39
2024-Q4
Increased
188,844
+26.5%
$1.5M0.0%$7.23
32
2024-Q3
Increased
149,280
+13.3%
$1.6M0.0%$10.80
29
2024-Q2
Increased
131,717
+45.4%
$1.5M0.0%$11.70
35

Other major holders of RGNX: BlackRock Finance, Inc., BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used